Intracoronary Imaging and Transcriptomic Characteristics Before and After Maximum Lipid-Lowering Therapy: YELLOW-III Study of Evolocumab and Maximum Statin Therapy in Chronic Coronary Disease.
Kini AS, Vengrenyuk Y, Liu J, Yasumura K, Revaiah PC, Mandava A, Shah H, Sweeny JM, Khera S, Kapur V, Melarcode-Krishnamoorthy P, Hooda A, Minatoguchi S, Baruah N, Pineda DA, Chen V, Ellis E, Hahn A, Krishnan P, Baber U, Moreno PR, Mehran R, Sebra R, Boerwinkle E, Zhou X, Narula J, Sharma SK. Kini... <a class="view-article" href="https://pitt.creatotech.com/intracoronary-imaging-and-transcriptomic-characteristics-before-and-after-maximum-lipid-lowering-therapy-yellow-iii-study-of-evolocumab-and-maximum-statin-therapy-in-chronic-coronary-disease/">View Article</a>
Read More